Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis
- PMID: 25977148
- DOI: 10.1007/s00438-015-1058-y
Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis
Abstract
A number of studies have investigated the associations between IL-10 polymorphisms and non-Hodgkin lymphoma (NHL) susceptibility; however, the conclusions were still contradictory. To acquire a more precise estimation of the association, we performed the current meta-analysis. We systematically searched publications from EMBASE and MEDLINE, and calculated pooled odds ratios (ORs) and 95 % confidence intervals (CIs) using either fixed-effects or random-effects model. Genotype-based IL-10 mRNA expression analysis was performed using online public database of 270 individuals with three different ethnicities. A total of 10,703 cases and 11,823 controls from 10 studies were included for the -3575T>A polymorphism, 10,226 cases and 12,215 controls from 17 studies for the -1082A>G polymorphism. Pooled results indicated that IL-10 -3575T>A was associated with increased risk of diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL), especially for Caucasians and hospital-based population. There was no association between IL-10 -1082A>G and NHL risk. However, subgroup analysis showed that IL-10 -1082GG might confer increased susceptibility to FL. In summary, this meta-analysis indicated that -3575T>A polymorphism was associated with altered NHL susceptibility for Caucasians and hospital-based population, especially for DLBCL and FL subtypes. The -1082A>G polymorphism may contribute to increased FL risk. Further large-scale population studies among different ethnicities are needed to validate these results.
Keywords: Interleukin-10; Meta-analysis; Non-Hodgkin lymphoma; Polymorphism.
Similar articles
-
Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.Hum Immunol. 2016 May;77(5):418-25. doi: 10.1016/j.humimm.2016.03.006. Epub 2016 Mar 19. Hum Immunol. 2016. PMID: 27006334
-
Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.Turk J Haematol. 2018 May 25;35(2):99-108. doi: 10.4274/tjh.2017.0106. Epub 2017 Jul 17. Turk J Haematol. 2018. PMID: 28713071 Free PMC article.
-
Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.Gene. 2013 May 1;519(2):288-94. doi: 10.1016/j.gene.2013.01.066. Epub 2013 Feb 26. Gene. 2013. PMID: 23485354
-
The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.Eur Rev Med Pharmacol Sci. 2014;18(4):544-52. Eur Rev Med Pharmacol Sci. 2014. PMID: 24610621 Review.
-
Role of Interleukin-10 (-1082A/G) gene polymorphism with the risk of ischemic stroke: a meta-analysis.Neurol Res. 2016 Sep;38(9):823-30. doi: 10.1080/01616412.2016.1202395. Epub 2016 Jun 30. Neurol Res. 2016. PMID: 27363685 Review.
Cited by
-
Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes.Cancer Epidemiol Biomarkers Prev. 2023 Feb 6;32(2):233-241. doi: 10.1158/1055-9965.EPI-22-0247. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36409490 Free PMC article.
-
Early Non-Response to Neoadjuvant Chemotherapy Will Increase the Recurrence of Cervical Cancer: A Systematic Review.Biomedicines. 2025 Aug 19;13(8):2016. doi: 10.3390/biomedicines13082016. Biomedicines. 2025. PMID: 40868267 Free PMC article. Review.
-
Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOP.Genomics Inform. 2016 Dec;14(4):205-210. doi: 10.5808/GI.2016.14.4.205. Epub 2016 Dec 30. Genomics Inform. 2016. PMID: 28154512 Free PMC article.
-
Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.Oncotarget. 2016 Jun 21;7(25):38762-38774. doi: 10.18632/oncotarget.9607. Oncotarget. 2016. PMID: 27246973 Free PMC article.
-
Thromboinflammatory Biomarkers in Lymphomas: Linking Inflammation to Thrombosis Risk.Int J Mol Sci. 2025 Feb 26;26(5):2058. doi: 10.3390/ijms26052058. Int J Mol Sci. 2025. PMID: 40076681 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources